{"id":"https://openalex.org/W159676469","doi":null,"title":"Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.","display_name":"Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.","publication_year":1990,"publication_date":"1990-04-01","ids":{"openalex":"https://openalex.org/W159676469","mag":"159676469","pmid":"https://pubmed.ncbi.nlm.nih.gov/1969270"},"language":"en","primary_location":{"id":"pmid:1969270","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1969270","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071802334","display_name":"Neil S. Buckholtz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N S Buckholtz","raw_affiliation_strings":["National Institute of Mental Health, Laboratory of Clinical Science, Bethesda, MD 20892"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute of Mental Health, Laboratory of Clinical Science, Bethesda, MD 20892","institution_ids":["https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108560201","display_name":"D-F Zhou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D F Zhou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112171700","display_name":"Daniel X. Freedman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D X Freedman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109177200","display_name":"W Z Potter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W Z Potter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.1517,"has_fulltext":false,"cited_by_count":80,"citation_normalized_percentile":{"value":0.85910653,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"3","issue":"2","first_page":"137","last_page":"48"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.020999999716877937,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lysergic-acid-diethylamide","display_name":"lysergic acid diethylamide","score":0.996999979019165},{"id":"https://openalex.org/keywords/serotonin-2-receptor","display_name":"serotonin 2 receptor","score":0.7170000076293945},{"id":"https://openalex.org/keywords/receptor-downregulation","display_name":"receptor down-regulation","score":0.9269999861717224},{"id":"https://openalex.org/keywords/behavioral-tolerance","display_name":"behavioral tolerance","score":0.7940000295639038},{"id":"https://openalex.org/keywords/psilocybin","display_name":"psilocybin","score":0.8550000190734863},{"id":"https://openalex.org/keywords/mescaline","display_name":"mescaline","score":1.0},{"id":"https://openalex.org/keywords/cross-tolerance","display_name":"cross-tolerance","score":0.8050000071525574}],"concepts":[{"id":"https://openalex.org/C124315065","wikidata":"https://www.wikidata.org/wiki/Q194270","display_name":"Hallucinogen","level":2,"score":0.9112823605537415},{"id":"https://openalex.org/C2776125444","wikidata":"https://www.wikidata.org/wiki/Q193140","display_name":"Mescaline","level":3,"score":0.9069308042526245},{"id":"https://openalex.org/C2779871769","wikidata":"https://www.wikidata.org/wiki/Q23118","display_name":"Lysergic acid diethylamide","level":4,"score":0.8931498527526855},{"id":"https://openalex.org/C200220013","wikidata":"https://www.wikidata.org/wiki/Q753586","display_name":"5-HT2 receptor","level":5,"score":0.764618456363678},{"id":"https://openalex.org/C2776502132","wikidata":"https://www.wikidata.org/wiki/Q208118","display_name":"Psilocybin","level":3,"score":0.6580560207366943},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5951136946678162},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5395521521568298},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5176109075546265},{"id":"https://openalex.org/C172773627","wikidata":"https://www.wikidata.org/wiki/Q753583","display_name":"5-HT1 receptor","level":5,"score":0.4667653739452362},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.430826336145401},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.42810195684432983},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.401762992143631},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.3568851947784424},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.18351399898529053},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14216309785842896}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002540","descriptor_name":"Cerebral Cortex","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007650","descriptor_name":"Ketanserin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008238","descriptor_name":"Lysergic Acid Diethylamide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008635","descriptor_name":"Mescaline","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009928","descriptor_name":"Organ Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011562","descriptor_name":"Psilocybin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011869","descriptor_name":"Radioligand Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011919","descriptor_name":"Rats, Inbred Strains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015536","descriptor_name":"Down-Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:1969270","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1969270","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","raw_type":"Journal Article"},{"id":"mag:159676469","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1969270","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2012834083","https://openalex.org/W2043279036","https://openalex.org/W2026107282","https://openalex.org/W1996628510","https://openalex.org/W1980348146","https://openalex.org/W2091625287","https://openalex.org/W2080123927","https://openalex.org/W2187905600","https://openalex.org/W2419284308","https://openalex.org/W4412464433"],"abstract_inverted_index":{"A":[0],"dosage":[1],"regimen":[2],"of":[3,29,38,100,115,206,224],"lysergic":[4],"acid":[5],"diethylamide":[6],"(LSD)":[7],"that":[8,182],"reliably":[9],"produces":[10],"behavioral":[11,207,225],"tolerance":[12,208,226],"in":[13,23,52,57,149],"rats":[14],"was":[15,95,104,120],"evaluated":[16],"for":[17,32,46,90,141,162,171],"effects":[18],"on":[19],"neurotransmitter":[20],"receptor":[21,34,74],"binding":[22,56,71,199,217],"rat":[24],"brain":[25],"using":[26],"a":[27,50,87,146],"variety":[28],"radioligands":[30],"selective":[31],"amine":[33],"subtypes.":[35],"Daily":[36],"administration":[37,102,117],"LSD":[39,101,110,116,183,212],"[130":[40],"micrograms/kg":[41],"(0.27":[42],"mumol/kg)":[43,140,161,170],"intraperitoneally":[44],"(IP)]":[45],"5":[47,113,163,172],"days":[48,99,114],"produced":[49,145],"decrease":[51,94,119,148],"serotonin2":[53],"(5-hydroxytryptamine2,":[54],"5-HT2)":[55],"cortex":[58],"(measured":[59],"24":[60],"hours":[61],"after":[62,107,129],"the":[63,108,118,130,154,202,215,222,231],"last":[64,131],"drug":[65],"administration)":[66],"but":[67,103,125,152,214],"did":[68],"not":[69,105,126],"affect":[70],"to":[72,86],"other":[73,185],"systems":[75],"(5-HT1A,":[76],"5-HT1B,":[77],"beta-adrenergic,":[78],"alpha":[79,82],"1-":[80],"or":[81,85,173],"2-adrenergic,":[83],"D2-dopaminergic)":[84],"recognition":[88],"site":[89],"5-HT":[91],"uptake.":[92],"The":[93,133],"evident":[96],"within":[97],"3":[98],"demonstrable":[106],"first":[109],"dose.":[111],"Following":[112],"still":[121],"present":[122],"48":[123],"hours,":[124,128],"96":[127],"administration.":[132],"indole":[134,186,232],"hallucinogen":[135],"psilocybin":[136],"[1.0":[137],"mg/kg":[138,159,168],"(3.5":[139],"8":[142],"days]":[143,164,175],"also":[144],"significant":[147],"5HT2":[150],"binding,":[151],"neither":[153],"nonhallucinogenic":[155],"analog":[156],"bromo-LSD":[157],"[1.3":[158],"(2.4":[160],"nor":[165],"mescaline":[166],"[10":[167],"(40.3":[169],"10":[174],"affected":[176],"5-HT2":[177,191,195,198],"binding.":[178],"These":[179],"observations":[180],"suggest":[181],"and":[184,204,227,233],"hallucinogens":[187],"may":[188],"act":[189],"as":[190],"agonists":[192],"at":[193],"postsynaptic":[194],"receptors.":[196],"Decreased":[197],"strikingly":[200],"parallels":[201],"development":[203],"loss":[205],"seen":[209],"with":[210],"repeated":[211],"administration,":[213],"decreased":[216],"per":[218],"se":[219],"cannot":[220],"explain":[221],"gamut":[223],"cross-tolerance":[228],"phenomena":[229],"among":[230],"phenylethylamine":[234],"hallucinogens.":[235]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}